High-Content & AI Phenotypic Imaging

Elevate your research with our state-of-the-art high-content imaging platforms that combine multiplexed fluorescent assays, deep morphological profiling, and sophisticated AI to decode complex cellular phenotypes at scale.

Our cell painting assay deploys a panel of fluorescent dyes staining various cellular organelles and compartments—including the nucleus, mitochondria, cytoskeleton, endoplasmic reticulum, and Golgi apparatus—to create a detailed phenotypic “fingerprint” of cells. Combined with automated high-throughput imaging, this assay enables comprehensive morphological profiling for drug screening, mechanism elucidation, and phenotypic drug discovery.

Using cutting-edge multiplexed AI-based morphology profiling, we extract thousands of quantitative features per cell. Machine learning algorithms then classify and cluster these profiles, revealing subtle phenotypic variations critical for identifying novel therapeutic targets and toxicities.

Our live-cell imaging capabilities capture real-time cellular events such as apoptosis, autophagy, and motility using advanced fluorescent reporters and time-lapse microscopy. These dynamic observations provide unparalleled insight into cellular responses to treatments, facilitating kinetic analyses and mechanistic studies.

We harness the power of machine learning (ML) to automate image processing and feature extraction, minimizing bias while maximizing throughput and reproducibility. Our robust pipelines integrate seamlessly with experimental workflows, delivering actionable phenotypic data rapidly and accurately to inform decision-making.